Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BIT/ARBS stock hub

BIT/ARBS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/ARBSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.3M

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/ARBS

In the news

Latest news · BIT/ARBS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13P50 15.3P75 18.4

Trailing P/E10.1

P25 14.4P50 21.2P75 24.6

ROE16.7

P25 3.1P50 8.5P75 13.3

ROIC19.4

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/ARBS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

EUR

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	34
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 19.2M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0005386369
Last refreshed	2026-05-10
Market cap	EUR 20.3M
Price	EUR 3.05
Price currency	EUR
Rev Per Employee	176,166.53x
Sector	Healthcare
Sic	2836
Symbol	bit/ARBS
Website	https://www.arterrabio.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.88%
EV Earnings	9.58x
EV/EBIT	9.95x
EV/EBITDA	8.65x
EV/FCF	12.49x
EV/Sales	3.21x
FCF yield	7.58%
P/B ratio	1.61x
P/E ratio	10.12x
P/S ratio	3.39x
PE Ratio10 Y	14.84x
PE Ratio3 Y	10.31x
PE Ratio5 Y	11.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.25%
EBITDA Margin	37.1%
FCF margin	25.69%
Gross margin	70.5%
Gross Profit	EUR 4.2M
Gross Profit Growth	90.13%
Gross Profit Growth Q	62.43%
Gross Profit Growth3 Y	34.2%
Gross Profit Growth5 Y	5.81%
Net Income	EUR 2M
Net Income Growth	65.74%
Net Income Growth Q	-0.98%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	24.88%
Net Income Growth5 Y	7.36%
Pretax Margin	33.35%
Profit Margin	33.5%
Profit Per Employee	EUR 59,008
Profitable Years	8
ROA	8.63
Roa5y	7.18
ROCE	14.1
ROE	16.72
Roe5y	13.14
ROIC	19.38
Roic5y	18.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	40.65%
Cagr3y	15.46%
Cagr5y	-0.57%
Div CAGR3	14.47%
EPS Growth Quarters	1
EPS Growth Years	1
FCF Growth	77.3%
OCF Growth	98.13%
OCF Growth Q	26.97%
Revenue Growth	71.61x
Revenue Growth Q	48.77x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	21.56x
Revenue Growth5 Y	6.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.43
Assets	EUR 14.6M
Cash	EUR 1.3M
Current Assets	EUR 8.3M
Current Liabilities	EUR 824,098
Debt	EUR 260,351
Debt EBITDA	EUR 0.12
Debt Equity	EUR 0.02
Debt FCF	EUR 0.17
Equity	EUR 12.6M
Liabilities	EUR 2M
Long Term Assets	EUR 6.3M
Long Term Liabilities	EUR 1.2M
Net Cash	EUR 1.1M
Net Cash By Market Cap	EUR 5.33
Net Cash Growth	-9.48%
Net Debt EBITDA	EUR -0.49
Net Debt Equity	EUR -0.09
Net Debt FCF	EUR -0.7
Tangible Book Value	EUR 12.6M
WACC	7.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.8
Inventory Turnover	1.23
Net Working Capital	EUR 4.7M
Quick ratio	6.05
Working Capital	EUR 6M
Working Capital Turnover	EUR 0.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	15.38%
Dividend Growth Years	1%
Dividend per share	EUR 0.13
Dividend Years	5
Dividend Yield	4.26%
Ex Div Date	2026-05-04
Last Dividend	EUR 0.15
Payout Frequency	Annual
Payout Ratio	42.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	40.62%
200-day SMA	2.92
3Y total return	53.95%
50-day SMA	2.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-2.84%
All Time High	5.34
All Time High Change	-42.88%
All Time High Date	2019-11-21
All Time Low	1.48
All Time Low Change	106.08%
All Time Low Date	2023-11-16
ATR	0.07
Beta	0.67
Beta1y	0.35
Beta2y	0.55
Ch YTD	0.99
High	3.08
High52	3.58
High52 Date	2025-10-09
High52ch	-14.8%
Low	3.04
Low52	2.2
Low52 Date	2025-05-20
Low52ch	38.64%
Ma50ch	4.45%
Price vs 200-day SMA	4.31%
RSI	52.58
RSI Monthly	61.86
RSI Weekly	54.81
Sharpe ratio	1.02x
Sortino ratio	1.9
Total Return	4.26%
Tr YTD	6.16
Tr1m	2.76%
Tr1w	4.1%
Tr3m	-1.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.9M
Operating Income Growth	45.53
Operating Income Growth Q	9.54
Operating Income Growth3 Y	28.36
Operating Income Growth5 Y	2.79
Operating margin	32.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,641,256%
Net Borrowing	-96,077
Shares Insiders	30.3%
Shares Out	6,658,493

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.5M
Average Volume	8,475x
CAPEX	EUR -453,293
Ch1m	-2.24
Ch1w	4.1
Ch1y	33.77
Ch3m	-5.86
Ch3y	26.03
Ch5y	-22.19
Ch6m	1.67
Change	0.66%
Change From Open	-0.97
Close	3.03
Days Gap	1.65
Depreciation Amortization	290,187
Dollar Volume	6,862.5
Earnings Date	2026-09-28
EBIT	EUR 1.9M
EBITDA	EUR 2.2M
F Score	6
FCF	EUR 1.5M
FCF EV Yield	8x
FCF Per Share	EUR 0.23
Financing CF	-942,777
Fiscal Year End	December
Founded	2,003
Income Tax	EUR -8,495
Investing CF	-3,050,081
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2024-12-31
Ma150	3.03
Ma150ch	0.69%
Ma20	3.06
Ma20ch	-0.23%
Net CF	-2,000,635
Next Earnings Date	2026-09-28
Open	3.08
P FCF Ratio	13.2
P OCF Ratio	10.19
Payment Date	2026-05-06
Position In Range	25
Ppne	1,508,180
Price Date	2026-05-08
Price EBITDA	EUR 9.14
Ptbv Ratio	1.62
Relative Volume	0.27x
Revenue	5,989,662x
Tax By Revenue	-0.14x
Tr6m	6.87%
Volume	2,250

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/ARBS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.3%

$0.13 annual per share

Payout ratio

+42.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+4.3%

Next ex-dividend date: 2026-05-04

Performance

BIT/ARBS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/ARBS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+30.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BIT/ARBS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.6

Neutral momentum band

Price vs 200-day MA

+4.3%

50/200-day relationship not available

Beta (5Y)

0.67

Less volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/ARBS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/ARBS stock rating?

bit/ARBS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/ARBS analysis?

The full report lives at /stocks/bit/ARBS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/ARBS?

The latest report frames bit/ARBS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/ARBS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.